Partnership Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Partnership Wealth Management's BMY Position: Q3 2026 in Review
Partnership Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 4.5% in Q3 2026, selling an estimated $89K and leaving 29,948 shares worth $1.87M. The position accounts for 1.33% of the portfolio, ranked #15.
Partnership Wealth Management first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.53M in Q1 2024. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Partnership Wealth Management held 29,948 shares of Bristol-Myers Squibb worth $1.87M as of Q3 2026.
- Partnership Wealth Management sold 1,408 Bristol-Myers Squibb shares in Q3 2026, an estimated $89K.
- Bristol-Myers Squibb made up 1.33% of Partnership Wealth Management's portfolio in Q3 2026, its #15 holding.
- Partnership Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
- Partnership Wealth Management's Bristol-Myers Squibb position peaked at $2.53M in Q1 2024.
- 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Partnership Wealth Management's 13F filing for Q3 2026, filed 5 Oct 2026.